Michael Bell
Förmögenhet: 6 M $ per 2026-05-31
Förmögenhet: 6 M $ per 2026-05-31
Michael Bell is currently Chief Financial Officer at Guardant Health, Inc. since 2021.
Formerly, Mr. Bell was Chief Financial & Accounting Officer at CareDx, Inc. from 2017 to 2020; Chief Financial Officer at Metabiota, Inc. from 2016 to 2017; CFO & Investors Relations Contact at Singulex, Inc. from 2012 to 2016; Head-Finance at Novartis Corp.
in 2012; Chief Financial Officer at Novartis Vaccines & Diagnostics, Inc. from 2011 to 2012; Chief Financial Officer at Novartis Pharma AG from 2011 to 2012; Finance Director at Chiron Corp.; Principal at Deloitte & Touche LLP; Principal at Ernst & Young LLP (Missouri).
Education includes undergraduate studies at the University of Leicester.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GUARDANT HEALTH, INC. 0,04 % | 2026-06-15 | 48 452 ( 0,04 % ) | 6 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| GUARDANT HEALTH, INC. | Finansdirektör/CFO | 2021-01-05 |
| Företag | Position | Slut |
|---|---|---|
| CAREDX, INC. | Finansdirektör/CFO | 2020-12-31 |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Finansdirektör/CFO | 2017-03-01 |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Finansdirektör/CFO | 2016-01-01 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Finansdirektör/CFO | 2012-01-01 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Finansdirektör/CFO | 2012-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Singulex, Inc.
Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Health Technology |
Metabiota, Inc.
Metabiota, Inc. Miscellaneous Commercial ServicesCommercial Services provides science and data analytics. | Commercial Services |
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån